Prevalence of high-risk HPV infection and genotyping in women who had ASC-US/LSIL cervical cytology.

Phase 1

Recruiting

• Conditions: ASC- US, LSIL, cervix, HPV, Healthy patients who had cervical cytology of ASC- US/LSIL; histopathology

• Registration Number: TCTR20161017002
• Lead Sponsor: Siriraj Research Development Fund

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-17
• Study Completion: 2017-10-11
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 421

Inclusion Criteria

1.Women who had cervical cytology of ASC-US/LSIL
2.Age ≥ 18 years
3.Non-pregnant women
4.Can use Thai language and sign in consent form

Exclusion Criteria

None

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Prevalence of high-risk HPV and genotyping 1.5 year rate in percent

Secondary Outcome Measures

Name	Time	Method
Correlation of HPV genotyping and pathology 1.5 year rate in percent, regression analysis